Exploring Drug Delivery to the Peritoneum
Intro -- Preface -- Acknowledgments -- Contents -- Peritoneal Organ-Anatomical and Physiological Considerations -- 1 Introduction -- 1.1 Developmental Considerations -- 1.2 Extraperitoneal Tissue -- 1.3 Anatomy of the Peritoneum -- 1.4 Peritoneal Cavity and Recesses -- 1.5 Physiology of Peritoneal Fluid -- 1.6 Splanchnic Circulation: Blood Supply, Venous Drainage, and Lymphatic Drainage -- 1.7 Innervation -- 1.8 Functional Correlations -- 1.9 Peritoneum in Herniorrhaphy -- 1.10 Peritonitis -- 1.11 Peritoneal Dialysis -- 2 Conclusion -- References -- Intraperitoneal Delivery Systems -- 1 Introduction -- 2 History of Intraperitoneal Delivery Systems -- 3 Principles of Intraperitoneal Delivery Systems -- 3.1 Criteria of Intraperitoneal Drug Delivery Systems -- 4 Methods of Intraperitoneal Delivery (IPD) -- 4.1 Direct Injection/Conventional IP Drug Delivery -- 4.2 Continuous Infusion/Implantable IP Drug Delivery Systems -- 5 Drugs for Intraperitoneal Delivery Systems -- 6 Conclusion -- References -- Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- 1 Introduction -- 2 Anatomy and Physiology of the Peritoneum -- 3 Plura and Peritoneal Drug Delivery Systems -- 4 Lipid-Based Nanoparticles as Peritoneal Drug Delivery: Status and Advances -- 5 Different Types of Liposomes and Lipid Nanoparticles -- 5.1 Liposomes -- 5.2 Solid Lipid Nanoparticles -- 5.3 Nanostructured Lipid Carriers -- 5.4 Nanoemulsions -- 5.5 Exosomes -- 5.6 Lipid Polymer Hybrid Nanoparticles -- 6 Lipid-Drug Conjugate -- 7 Peritoneal Targeting by Nanocarriers -- 8 Cell and Molecular Biology of Peritoneal Drug Delivery -- 9 Clinical Status -- 10 Conclusion -- References -- Nano- and Micromedicines as Intraperitoneal Therapy in Ovarian Cancer: Critical Overview and Focus on Pharmaceutical Manufacturing Under cGMP -- 1 Introduction..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2024 ©2023 |
|---|---|
| Erschienen: |
Cham: Springer International Publishing AG ; 2024 ©2023 |
| Ausgabe: |
1st edition |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shegokar, Ranjita [HerausgeberIn] |
|---|
| Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Anmerkungen: |
Description based on publisher supplied metadata and other sources |
|---|
| Umfang: |
1 Online-Ressource (244 Seiten) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1879983079 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1879983079 | ||
| 003 | DE-627 | ||
| 005 | 20240206104209.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240205s2024 xx |||||o 00| ||eng c | ||
| 020 | |a 9783031316944 |9 978-3-031-31694-4 | ||
| 035 | |a (DE-627)1879983079 | ||
| 035 | |a (DE-599)KEP09922139X | ||
| 035 | |a (EBC)EBC30980177 | ||
| 035 | |a (EBL)EBL30980177 | ||
| 035 | |a (EBP)09922139X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | |a 616.38061 | |
| 245 | 1 | 0 | |a Exploring Drug Delivery to the Peritoneum |
| 250 | |a 1st edition | ||
| 264 | 1 | |a Cham |b Springer International Publishing AG |c 2024 | |
| 264 | 4 | |c ©2023 | |
| 300 | |a 1 Online-Ressource (244 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 520 | |a Intro -- Preface -- Acknowledgments -- Contents -- Peritoneal Organ-Anatomical and Physiological Considerations -- 1 Introduction -- 1.1 Developmental Considerations -- 1.2 Extraperitoneal Tissue -- 1.3 Anatomy of the Peritoneum -- 1.4 Peritoneal Cavity and Recesses -- 1.5 Physiology of Peritoneal Fluid -- 1.6 Splanchnic Circulation: Blood Supply, Venous Drainage, and Lymphatic Drainage -- 1.7 Innervation -- 1.8 Functional Correlations -- 1.9 Peritoneum in Herniorrhaphy -- 1.10 Peritonitis -- 1.11 Peritoneal Dialysis -- 2 Conclusion -- References -- Intraperitoneal Delivery Systems -- 1 Introduction -- 2 History of Intraperitoneal Delivery Systems -- 3 Principles of Intraperitoneal Delivery Systems -- 3.1 Criteria of Intraperitoneal Drug Delivery Systems -- 4 Methods of Intraperitoneal Delivery (IPD) -- 4.1 Direct Injection/Conventional IP Drug Delivery -- 4.2 Continuous Infusion/Implantable IP Drug Delivery Systems -- 5 Drugs for Intraperitoneal Delivery Systems -- 6 Conclusion -- References -- Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- 1 Introduction -- 2 Anatomy and Physiology of the Peritoneum -- 3 Plura and Peritoneal Drug Delivery Systems -- 4 Lipid-Based Nanoparticles as Peritoneal Drug Delivery: Status and Advances -- 5 Different Types of Liposomes and Lipid Nanoparticles -- 5.1 Liposomes -- 5.2 Solid Lipid Nanoparticles -- 5.3 Nanostructured Lipid Carriers -- 5.4 Nanoemulsions -- 5.5 Exosomes -- 5.6 Lipid Polymer Hybrid Nanoparticles -- 6 Lipid-Drug Conjugate -- 7 Peritoneal Targeting by Nanocarriers -- 8 Cell and Molecular Biology of Peritoneal Drug Delivery -- 9 Clinical Status -- 10 Conclusion -- References -- Nano- and Micromedicines as Intraperitoneal Therapy in Ovarian Cancer: Critical Overview and Focus on Pharmaceutical Manufacturing Under cGMP -- 1 Introduction. | ||
| 700 | 1 | |a Shegokar, Ranjita |e herausgeberin |4 edt | |
| 776 | 1 | |z 9783031316937 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031316937 |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=30980177 |m X:EBC |x Aggregator |z lizenzpflichtig |
| 912 | |a ZDB-30-PQE | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a ISIL_DE-84 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.38061 | ||
| 980 | |2 20 |1 01 |x 0084 |b 4476519547 |h CATDESC_EBC-EB |u CATDESC_EBC-EB |y z |z 06-02-24 | ||
| 981 | |2 20 |1 01 |x 0084 |r https://ebookcentral.proquest.com/lib/tubraunschweig-ebooks/detail.action?docID=30980177 | ||
| 995 | |2 20 |1 01 |x 0084 |a CATDESC_EBC-EB | ||
| 995 | |2 20 |1 01 |x 0084 |a ACQ | ||